Israeli Technology Company BYND Cannasoft Enterprises Inc. Announces Contract for Its Benefit CRM Cloud-Based Software as a Service CRM Platform
ASHKELON, Israel and VANCOUVER, British Columbia, Nov. 17, 2022 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) (“BYND Cannasoft” or the “Company”) announced today that it has signed an agreement for the provision of software services with one of Israel’s leading air conditioning companies. Under the terms of the agreement, the Company will provide Benefit CRM Cloud-Based Software as a Service (SaaS) in special modules that include mobile applications and APIs.
Family - Line Air Conditioner Company sells hundreds of thousands of air conditioners and is the fourth largest company in the production, marketing, and installation of air conditioners in Israel. BYND Cannasoft will design and manufacture modules dedicated to this sector with the intent of realizing the strategy and penetrating additional companies and deepening services in consumer goods companies.
“The air conditioning industry generates billions of shekels in revenue every year in Israel and has enjoyed increasing growth in recent years,” said Yftah Ben Yaackov, CEO and Director of BYND. “This agreement demonstrates the mutual commitment of BYND Cannasoft and Family-Line Air Conditioners to serving the needs of customers, as well as optimizing day-to-day functions.”
BYND Cannasoft’s Benefit CRM enables small and medium-sized enterprises to optimize day-to-day functions, such as sales management, workforce management, contact center operations, and asset management. Benefit CRM is provisioned as SaaS to some of Israel's most recognizable companies. The Company has been marketing its Benefit CRM to approximately 400 clients with a monthly recurring revenue model for nearly 20 years.
About BYND Cannasoft Enterprises Inc.
BYND is an Israeli-based integrated software and cannabis company.
BYND owns and markets a proprietary customer relationship management (CRM) software product, known as “Benefit CRM”. BYND’s Benefit CRM software enables small and medium-sized businesses to optimize their day-to-day business activities such as sales management, personnel management, marketing, call center activities, and asset management. BYND’s next-generation Benefit CRM platform is now ready for BETA testing.
Medical Cannabis Business
BYND holds an initial approval from the Medical Cannabis Unit in the Ministry of Health of the State of Israel, for a contactless business license that allows trading in medical cannabis products without contact with the actual substance. This is a unique license that is held by only a limited number of companies in Israel. The Company is in the final stages of obtaining the full license and immediately after receiving it, the Company plans to operate through a licensed medical cannabis farm for the production of the Company's private label for various products and varieties. The products will be produced for the Company and marketed to the pharmacies while paying a commission to the grower for the cultivation and processing of the substance. The Company anticipates that if the license is received in the coming months, it will be possible to market the products immediately and capture a significant market share which can generate significant income for the Company.
For Further Information please refer to information available on the Company’s website: www.cannasoft-crm.com, the CSE’s website: www.thecse.com/en/listings/life-sciences/bynd-cannasoft-enterprises-inc and on SEDAR: www.sedar.com.
For Media and Investor Relations, please contact:
David L. Kugelman
(866) 692-6847 Toll Free - U.S. & Canada
(404) 281-8556 Mobile and WhatsApp
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements that involve risks and uncertainties, which may cause actual results to differ materially from the statements made. When used in this document, the words “may”, “would”, “could”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” and similar expressions are intended to identify forward-looking statements. Such statements reflect the Company’s current views with respect to future events and are subject to such risks and uncertainties. Many factors could cause actual results to differ materially from the statements made, including unanticipated regulatory requests and delays, and those factors discussed in filings made by the Company with the Canadian securities regulatory authorities, including (without limitation) in the Company’s management’s discussion and analysis for the nine month period ended September 30, 2022 and annual information form dated October 8, 2022, which are available under the Company’s profile at www.sedar.com, and in filings made with the U.S. Securities and Exchange Commission. Should one or more of these risks and uncertainties, such as currency and interest rate fluctuations, increased competition, and general economic and market factors, occur or should assumptions underlying the forward-looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, or expected. We do not intend and do not assume any obligation to update these forward-looking statements, except as required by law. Shareholders are cautioned not to put undue reliance on such forward-looking statements.